The goal is to explore the misregulation of Tau in ARSACS, and evaluate the efficacy of modulating levels of Tau and associated kinases in the ARSACS mouse model.
Grant : $139,962
Contact:
Dr. Anthony Hickey, Director of UNC Catalyst for Rare Diseases, University of North Carolina
120 Mason Farm Road CB# 7356, Chapel Hill NC 27599
Tel: (919) 962-9819
ahickey@unc.edu
Dr.Justin Wolter
120 Mason Farm Road CB# 7356, Chapel Hill NC 27599
Tel: (919) 962-9819
justin_wolter@med.unc.edu